Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Haematology|July 15, 2011
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomasGaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 18, 2014
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphomaLuigi Aloj, Laura D'Ambrosio, Michela Aurilio, et al.
European Journal of Radiology|July 18, 2021
Imaging and treatment of brain tumors through molecular targeting: Recent clinical advancesFulvio Zaccagna, James T Grist, Natale Quartuccio, et al.
Nuclear Medicine and Biology|June 22, 2020
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapyLuigi Aloj, Bala Attili, Doreen Lau, et al.
Endocrine|August 6, 2015
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)Secondo Lastoria, Francesca Marciello, Antongiulio Faggiano, et al.
EJNMMI Research|October 21, 2025
In vivo gastrin releasing peptide receptor expression in SDH deficient wild-type gastrointestinal stromal tumours (GIST): potential for theranostic applicationsDavid G E Hulse, Ines Harper, Fung Tan, et al.
Plos One|January 7, 2017
Sequential PET/CT with [18F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression AnalysisBiagio Pecori, Secondo Lastoria, Corradina Caracò, et al.
EJNMMI Research|July 16, 2020
Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRILaura M Lechermann, Roido Manavaki, Bala Attili, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2019
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal CancerAntonio Avallone, Luigi Aloj, Biagio Pecori, et al.
Frontiers in Endocrinology|November 28, 2022
The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature reviewCalum Urquhart, Ben Fleming, Ines Harper, et al.
Pageof 9